"In the event CD12 is successful and we are able to uplist, I thought it would be interesting to consider how big CYDY's market cap could become."
From prior market cap gains with an EUA, Gilead gained $10 Billion in market. At that amount, would put us at a SP of $17.55. Of course this does not factor an Uplist.